Active monitoring of adverse drug reactions to the use of beta-lactam antibiotics in the treatment of community-acquired pneumonia

E. Torgunakova (Krasnoyarsk, Russian Federation), E. Bochanova (Krasnoyarsk, Russian Federation), I. Demko (Krasnoyarsk, Russian Federation), A. Kraposhina (Krasnoyarsk, Russian Federation), E. Kurts (Krasnoyarsk, Russian Federation)

Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Session: Cardiovascular and pulmonary complications of respiratory infections
Session type: E-poster session
Number: 1781
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Torgunakova (Krasnoyarsk, Russian Federation), E. Bochanova (Krasnoyarsk, Russian Federation), I. Demko (Krasnoyarsk, Russian Federation), A. Kraposhina (Krasnoyarsk, Russian Federation), E. Kurts (Krasnoyarsk, Russian Federation). Active monitoring of adverse drug reactions to the use of beta-lactam antibiotics in the treatment of community-acquired pneumonia. 1781

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: